{"id":471866,"date":"2021-04-06T09:48:23","date_gmt":"2021-04-06T13:48:23","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=471866"},"modified":"2021-04-06T09:48:23","modified_gmt":"2021-04-06T13:48:23","slug":"biosig-lands-commercial-sales-to-leading-hospital-system","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/","title":{"rendered":"BioSig lands Commercial Sales to Leading Hospital System"},"content":{"rendered":"<div class=\"mw_release\">\n<p>Westport, CT, April  06, 2021  (GLOBE NEWSWIRE) &#8212; <\/p>\n<ul>\n<li>\n          <strong>World class healthcare institution adopts PURE EP\u2122\u00a0 across multiple States<\/strong>\n        <\/li>\n<li>\n          <strong>Medical centers resuming elective procedures helps drive sales acceleration<\/strong>\n        <\/li>\n<\/ul>\n<p>BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that a top rated leading hospital system purchased PURE EP\u2122 systems for multiple campuses in their national network.<\/p>\n<p>\u201cWe are pleased to expand our commercial installations across this most important healthcare system in multiple states.\u201d commented Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc.\u00a0 \u201cWe expect to see further commercial sales in coming weeks and months\u201d<\/p>\n<p>More than 680 patient cases have been conducted with the PURE EP\u2122 System to date across eight clinical sites. \u00a0The PURE EP\u2122 System is being used in all types of arrhythmia cases, including atrial fibrillation, ventricular tachycardia, and atrial flutter. \u00a0The Company continues to accumulate significant amounts of data to be utilized in the development of its AI platform.<\/p>\n<p>The Company previously announced that it completed its <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qIVNidlG4iIKOlz-5lXrlplQ9wr1_WO2MpOvlVe_PKSY1MudwhwXuxk1FljMetyKE8yPrzUzYLH6ixp0Av9yYHsoZBHRKVxiBwySmkbffd_w4_Gqyi1nW_riqQMR0RpgI9rVVCvdstVqc2EAj10KNTrosg7JjxlpGkFMzWG2V9sPLXKAIf-65MJZ2zA-8xXAdGf5Mz4yiCoxn_pKwtzhug==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>first commercial sale<\/u><\/a> of PURE EP\u2122 Systems to St. David\u2019s HealthCare of Austin, Texas, an HCA Healthcare-owned hospital. \u201cWe are excited to see leading electrophysiologists and institutions commercially adopt the PURE EP\u2122 system which we believe demonstrates acceptance of the unique benefits of our system platform, software, and data,\u201d added Londoner.<br \/><strong><br \/> About BioSig Technologies<br \/><\/strong>BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to\u00a0improve signal fidelity and uncover the full range of ECG and intra-cardiac signals\u00a0(<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HtGRR7XosO-tdUxAdPkVkjacw9hlopoCPMZcDfwNLDGvgD_qppGuBCzI8oE6obocyCEkKqf0TEsH-edClKASJA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.biosig.com<\/u><\/a>).<\/p>\n<p>The Company\u2019s first product,\u00a0PURE EP\u2122 System\u00a0is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.<\/p>\n<p>Follow BioSig Technologies, Inc. on Twitter at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yqrqkeZCvfBWaTZppg-nU-f87eOpNH7hzPcFCdp9siESzjThYzo0Se8grqxxU_qNJckPaB0nV2njKo6YQPk-EYXmnC4XbovLD5FEAhBQTxbDHW9yyYB5pW0FCgwqPMkPbOiag_Vs4FFzwJ7xEfH-BbiOjBYY2g7GSjgmiYII3Uc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">@Biosig_tech<\/a><\/p>\n<p>\n        <strong>Forward-looking Statements <\/strong>\n      <\/p>\n<p>This press release contains \u201cforward-looking statements.\u201d Such statements may be preceded by the words \u201cintends,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cplans,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cprojects,\u201d \u201cpredicts,\u201d \u201cestimates,\u201d \u201caims,\u201d \u201cbelieves,\u201d \u201chopes,\u201d \u201cpotential\u201d or similar words. Forward- looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company\u2019s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) the geographic, social and economic impact of COVID-19 on our ability to conduct our business and raise capital in the future when needed, (ii) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (iii) difficulties in obtaining financing on commercially reasonable terms; (iv) changes in the size and nature of our competition; (v) loss of one or more key executives or scientists; and (vi) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company\u2019s filings with the Securities and Exchange Commission (SEC), including the Company\u2019s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC\u2019s website at http:\/\/www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. <\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/d20a3fa2-27fc-4995-aac3-f61b49a532c1\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Andrew Ballou\r\nBioSig Technologies, Inc. \r\nVice President, Investor Relations \r\n54 Wilton Road, 2nd floor\r\nWestport, CT 06880\r\naballou@biosigtech.com\r\n203-409-5444, x133\r\n\r\n<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Westport, CT, April 06, 2021 (GLOBE NEWSWIRE) &#8212; World class healthcare institution adopts PURE EP\u2122\u00a0 across multiple States Medical centers resuming elective procedures helps drive sales acceleration BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that a top rated leading hospital system purchased PURE EP\u2122 systems for multiple campuses in their national network. \u201cWe are pleased to expand our commercial installations across this most important healthcare system in multiple states.\u201d commented Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc.\u00a0 \u201cWe expect to see further commercial sales in coming weeks and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioSig lands Commercial Sales to Leading Hospital System&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-471866","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioSig lands Commercial Sales to Leading Hospital System - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioSig lands Commercial Sales to Leading Hospital System - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Westport, CT, April 06, 2021 (GLOBE NEWSWIRE) &#8212; World class healthcare institution adopts PURE EP\u2122\u00a0 across multiple States Medical centers resuming elective procedures helps drive sales acceleration BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that a top rated leading hospital system purchased PURE EP\u2122 systems for multiple campuses in their national network. \u201cWe are pleased to expand our commercial installations across this most important healthcare system in multiple states.\u201d commented Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc.\u00a0 \u201cWe expect to see further commercial sales in coming weeks and &hellip; Continue reading &quot;BioSig lands Commercial Sales to Leading Hospital System&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-06T13:48:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioSig lands Commercial Sales to Leading Hospital System\",\"datePublished\":\"2021-04-06T13:48:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/\"},\"wordCount\":614,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/\",\"name\":\"BioSig lands Commercial Sales to Leading Hospital System - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg=\",\"datePublished\":\"2021-04-06T13:48:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-lands-commercial-sales-to-leading-hospital-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioSig lands Commercial Sales to Leading Hospital System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioSig lands Commercial Sales to Leading Hospital System - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/","og_locale":"en_US","og_type":"article","og_title":"BioSig lands Commercial Sales to Leading Hospital System - Market Newsdesk","og_description":"Westport, CT, April 06, 2021 (GLOBE NEWSWIRE) &#8212; World class healthcare institution adopts PURE EP\u2122\u00a0 across multiple States Medical centers resuming elective procedures helps drive sales acceleration BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that a top rated leading hospital system purchased PURE EP\u2122 systems for multiple campuses in their national network. \u201cWe are pleased to expand our commercial installations across this most important healthcare system in multiple states.\u201d commented Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc.\u00a0 \u201cWe expect to see further commercial sales in coming weeks and &hellip; Continue reading \"BioSig lands Commercial Sales to Leading Hospital System\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-06T13:48:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioSig lands Commercial Sales to Leading Hospital System","datePublished":"2021-04-06T13:48:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/"},"wordCount":614,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/","name":"BioSig lands Commercial Sales to Leading Hospital System - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg=","datePublished":"2021-04-06T13:48:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjIxNCM0MTA3Nzg2IzIwMTgwNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-lands-commercial-sales-to-leading-hospital-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioSig lands Commercial Sales to Leading Hospital System"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/471866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=471866"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/471866\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=471866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=471866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=471866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}